ES2094815T3 - Composicion terapeutica y proceso para su preparacion. - Google Patents

Composicion terapeutica y proceso para su preparacion.

Info

Publication number
ES2094815T3
ES2094815T3 ES91913139T ES91913139T ES2094815T3 ES 2094815 T3 ES2094815 T3 ES 2094815T3 ES 91913139 T ES91913139 T ES 91913139T ES 91913139 T ES91913139 T ES 91913139T ES 2094815 T3 ES2094815 T3 ES 2094815T3
Authority
ES
Spain
Prior art keywords
active substance
pct
cover layer
matrix
colon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913139T
Other languages
English (en)
Inventor
Peter Edman
Arne Kristensen
Bengt Wideholt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of ES2094815T3 publication Critical patent/ES2094815T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTA UNA COMPOSICION FARMACEUTICA SELECTIVA PARA EL COLON PARA EL SUMINISTRO ORAL DE UNA O MAS SUBSTANCIAS TERAPEUTICAMENTE ACTIVAS, LA COMPOSICION COMPRENDE I) UN NUCLEO DE MATRIZ QUE TIENE LA SUBSTANCIA O SUBSTANCIAS ACTIVAS DISPERSAS EN EL MISMO, Y II) UNA CAPA DE CUBIERTA EXTERIOR SIN NINGUNA SUBSTANCIA ACTIVA, DICHO NUCLEO EN FORMA DE MATRIZ Y LA CAPA DE CUBIERTA SON SELECTIVAMENTE DEGRADABLES POR ENZIMAS QUE NORMALMENTE EXISTEN EN EL COLON. UN METODO PARA PREPARAR DICHA COMPOSICION FARMACEUTICA SELECTIVA PARA EL COLON COMPRENDE LOS PASOS DE MEZCLAR AL MENOS UNA SUBSTANCIA TERAPEUTICAMENTE ACTIVA CON UN MATERIAL DE MATRIZ PARA PREPARAR UN NUCLEO DE MATRIZ QUE TENGA LA SUBSTANCIA O SUBSTANCIAS ACTIVAS DISPERSAS EN EL MISMO, Y RECUBRIR DICHO NUCLEO DE MATRIZ CON UN MATERIAL SIN NINGUNA SUBSTANCIA ACTIVA EN EL MISMO PARA PROVEER AL NUCLEO DE MATRIZ DE UNA CAPA DE CUBIERTA PROTECTORA LIBRE DE DROGAS, DICHOS MATERIALES DE MATRIZ Y DE CUBIERTA ESTAN BASADOS EN AL MENOS UNA SUBSTANCIAQUE ES SELECTIVAMENTE DEGRADABLE POR ENZIMAS QUE SE ENCUENTRAN EN EL COLON.
ES91913139T 1990-07-04 1991-07-03 Composicion terapeutica y proceso para su preparacion. Expired - Lifetime ES2094815T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002339A SE9002339L (sv) 1990-07-04 1990-07-04 Terapeutisk komposition och foerfarande foer dess framstaellning

Publications (1)

Publication Number Publication Date
ES2094815T3 true ES2094815T3 (es) 1997-02-01

Family

ID=20379936

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913139T Expired - Lifetime ES2094815T3 (es) 1990-07-04 1991-07-03 Composicion terapeutica y proceso para su preparacion.

Country Status (11)

Country Link
US (1) US5505966A (es)
EP (1) EP0610178B1 (es)
JP (1) JPH05508156A (es)
AT (1) ATE145132T1 (es)
AU (1) AU8227291A (es)
DE (1) DE69123159T2 (es)
DK (1) DK0610178T3 (es)
ES (1) ES2094815T3 (es)
GR (1) GR3022337T3 (es)
SE (1) SE9002339L (es)
WO (1) WO1992000732A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK89592D0 (da) * 1992-07-07 1992-07-07 Helle Broendsted Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
ES2068154B1 (es) * 1993-07-13 1995-11-16 Cantabria Ind Farmaceutica Sa Nuevas formulaciones analgesicas con amplio intervalo de accion.
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
DE4331539A1 (de) * 1993-09-17 1995-03-23 Basf Ag Dextranester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Umhüllung oder Einbettung von Arzneimitteln
US5840860A (en) * 1993-11-17 1998-11-24 Commonwealth Scientific And Industrial Research Organization Fatty acid delivery system comprising a hydrolyzable bond
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
WO1997027843A2 (en) * 1996-01-30 1997-08-07 Advanced Polymer Systems, Inc. Targeted delivery of drugs to the lower gastrointestinal tract
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
KR100219918B1 (ko) 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
US6962717B1 (en) 1999-01-29 2005-11-08 Disphar International B.V. Pharmaceutical compositions
CN1285333C (zh) * 2000-06-07 2006-11-22 张昊 结肠定位释放的口服制剂及其制备方法
US6720005B1 (en) 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
EP1174127A1 (en) * 2000-07-21 2002-01-23 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Composition for targeted release of an actvie substance and process for producing such a composition
EP1315777B1 (en) * 2000-09-06 2007-10-31 AP Pharma, Inc. Degradable polyacetal polymers
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
AU2002358270A1 (en) * 2001-12-20 2003-07-09 Pharmacia Corporation Zero-order sustained released dosage forms and method of making the same
FR2843301B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US20070258879A1 (en) * 2005-12-13 2007-11-08 Philip Morris Usa Inc. Carbon beads with multimodal pore size distribution
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
US20090269405A1 (en) * 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
ZA200903858B (en) * 2008-06-19 2013-10-30 Univ Of Witwatesrand Johannesburg Pharmaceutical dosage form
CZ302789B6 (cs) * 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva
KR20190026648A (ko) * 2016-03-30 2019-03-13 바이탈 베버리지스 글로벌 인크. 선택적 위장관 전달을 위한 조성물 및 방법
JP2026510263A (ja) * 2023-02-24 2026-04-02 グランビア・デアリー・ニュートリション・リミテッド 常温保存可能な有機ヌクレオチド組成物およびその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4042073A (en) * 1976-05-27 1977-08-16 Dana Corporation Disc brake mechanism actuating means
US4507327A (en) * 1983-05-23 1985-03-26 Q.P. Corporation Process for preparing edible products in the form of capsules
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
JP2668730B2 (ja) * 1988-03-09 1997-10-27 雪印乳業株式会社 天然ポリマーを用いた徐放性製剤
FR2645439B1 (fr) * 1989-04-07 1991-06-21 Oreal Procede de preparation de capsules d'alginate(s) particulierement adaptees a un usage cosmetique, appareil pour sa mise en oeuvre et composition cosmetique contenant lesdites capsules

Also Published As

Publication number Publication date
JPH05508156A (ja) 1993-11-18
EP0610178B1 (en) 1996-11-13
AU8227291A (en) 1992-02-04
DK0610178T3 (da) 1997-04-14
US5505966A (en) 1996-04-09
GR3022337T3 (en) 1997-04-30
WO1992000732A1 (en) 1992-01-23
EP0610178A1 (en) 1994-08-17
DE69123159D1 (de) 1996-12-19
SE9002339L (sv) 1992-01-05
SE9002339D0 (sv) 1990-07-04
DE69123159T2 (de) 1997-04-10
ATE145132T1 (de) 1996-11-15

Similar Documents

Publication Publication Date Title
ES2094815T3 (es) Composicion terapeutica y proceso para su preparacion.
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
EP0013606A3 (en) Polymeric diffusion matrix, method of its preparation and drug delivery device comprising said matrix
DE68908456D1 (de) Matrix zur wirkstoffabgabe.
AU1534699A (en) Osmotic dosage form comprising first and second coats
ATE226815T1 (de) Herstellung von arzneimitteln
NO954582L (no) Blanding for nasal administrering av nikotin
ATE349203T1 (de) Delavirdin tablettenformulierung
FI103091B (fi) Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi
IL72763A0 (en) Polyol esters,their preparation and their use as depot matrix material for pharmacologically active substances
ATE322892T1 (de) Stabilisierte tramadol formulierungen mit verzögerter freisetzung
DE69923200D1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
FI932761A0 (fi) Foerfarande foer framstaellning av aktiva substanser innehaollande mikropartiklar av hydrolytiskt nedbrytbara polymerer
EE200000039A (et) MHC II klassi ligandi kasutamine, farmatseutiline kompositsioon, transfekteeritud kasvajarakud, transfekteeritud rakkude ja kasvajarakkude valmistamismeetod ning nende kasutamine
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
FR2718020B1 (fr) Composition galénique mucoadhésive hétérofonctionnelle.
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
SE8601457D0 (sv) Compositions of liposomes and b?712-receptor active substances for inhalation
YU48663B (sh) Flaster koji sadrži nitroglicerin i postupak za njegovo dobijanje
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
ATE185067T1 (de) Estradiol-tts mit wasserbindenden zusätzen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 610178

Country of ref document: ES